Cellix Bio

The Company that never stops innovating and inventing

Synergix AI powered technology

Our AI-driven analysis of large datasets has potential to transform the classic R&D pipeline into new ways of more precise target selection and accelerating multiple stages of development

Harnessing the data

Synergix AI is pioneering a transformative new big data approach to discovery and development of treatments provides more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems

Accelerating treatments

At Cellix Bio, the therapeutic lead discovery is rapid, smarter and safer, and strengthens our team and partners in achieving and translating new treatments towards the clinic

Intellectual Property

Our patent portfolio includes several issued patents and patent applications in the world’s major markets. We are constantly expanding, broadening and developing our intellectual property portfolio

What We Do

Cellix Bio is an innovative biopharmaceutical company dedicated to the development of proprietary molecular therapeutics that enhance one or more of the attributes of approved drugs, such as efficacy, therapeutic index, bioavailability and safety.

Our business model aims to create value with a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our mission is to participate in the promise of the biotech industry with a profitable, diversified business that is lower in risk than a typical biotech company. We aspire to contribute positively to the healthcare system, and improve the lives of patients around the world. Cellix Bio therapeutic portfolio is focused on diverse therapeutic areas including neurology, dermatology, gastrointestinal, inflammation, metabolic & life style, oncology, ophthalmology and infectious diseases.

Cellix Bio intends to develop targeted therapies

Know More
Featured Box Image

Platform Technologywe have built our firm on eminent science and a profound understanding of the biology behind diseases

Read More
Featured Box Image

Intellectual Property143 international patents published, obtained 63 Composition of Matter Issued U.S Patents from the USPTO

Read More
Featured Box Image

PipelineDrugs with important functional advantages and the capability to deliver both clinical and commercial successes

Read More

Cellix Bio Therapeutic Focused Portfolio

Oncology

Welcome to a better way to Live your Life.

Know More

Ophthalmology

Welcome to a better way to Live your Life.

Know More

Neurology

Welcome to a better way to Live your Life.

Know More

Gastrointestinal

Welcome to a better way to Live your Life.

Know More

Anti-Mycotics

Welcome to a better way to Live your Life.

Know More

Metabolic Diseases

Welcome to a better way to Live your Life.

Know More

Pain and Inflammation

Welcome to a better way to Live your Life.

Know More

Dermatology

Welcome to a better way to Live your Life.

Know More

Superior in transformation of ideas

Building a biopharmaceutical company with selective new technologies, ideas, medicines, and insights leading to superior transformation of ideas; our core competence is to develop and commercialize therapeutic drug products with less development risk and unique benefits for patients within our therapeutic areas of focus

Know More

Therapeutic Benefits

Cellix Bio uses it’s proprietary Synergix technology to develop New Molecular Entities with novel chemical structures that target known pathophysiological pathways most likely to yield significant therapeutic benefits.

Strong scientific platform Synergix

Using our proprietary technologies and our “Synergix” scientific platform, we are developing new medicines that modulate more than one target in the disease pathway, which potentially improves efficacy and minimizes risk in the discovery and development process.

Know More

Team Work

Our team has unique scientific and entrepreneurial experience in the life science industry, including R & D management, formulation development, and business development in renowned biopharmaceutical companies.

Read More
Chrome